Alzheimer's Dementia Archives - Page 2 of 3

Unmet Needs In Agitation Associated With Alzheimer’s Dementia (AAD)

Live Event October 23, 2024 6:30 pm to 8:30 pm EDT

This evidence-based review highlights important aspects of agitation associated with Alzheimer’s Dementia (AAD) for better understanding of the prevalence and challenges in diagnosis and explore the potential pathobiological correlations in… Read More

The Agitation in Alzheimer’s Screener For Caregivers (AASC™) – A New Tool To Disease Recognition

Live Event October 15, 2024 6:30 pm to 8:00 pm CDT

This presentation focuses on defining agitation in Alzheimer’s dementia including symptom presentation, prevalence and burden on patients and caregivers. Read More

Virtual Event – The Agitation in Alzheimer’s Screener For Caregivers (AASC™) – A New Tool To Disease Recognition

Regional/Local October 17, 2024 2:00 pm to 3:00 pm EDT

Michelle Lavagnino, DrPH(c) and Becky Wong, PharmD, MBA are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) Read More

The Agitation in Alzheimer’s Screener For Caregivers (AASC™) – A New Tool To Disease Recognition

Live Event September 26, 2024 6:30 pm to 8:00 pm CDT

Amaka Onyereri, PharmD, BCPS (OPDC) is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization… Read More

Unmet Needs In Agitation Associated With Alzheimer’s Dementia (AAD)

Live Event September 17, 2024 6:30 pm to 8:00 pm CDT

Unmet Needs In Agitation Associated With Alzheimer’s Dementia (AAD)

Live Event August 22, 2024 6:30 pm to 8:30 pm CDT

The Agitation in Alzheimer’s Screener for Caregivers (AASC™): How Caregivers Can Use This New Screener to Recognize the Breadth of Agitation Symptoms & Facilitate Conversations With Healthcare Professionals

On-Demand Webinar August 2, 2024

As a follow-up to the previous webinar, “An Introduction to the AASC™,” this webinar will re-ground on the current landscape of Alzheimer’s dementia (AD) and the negative impact agitation in… Read More

Unmet Needs In Agitation Associated With Alzheimer’s Dementia (AAD)

Live Event August 22, 2024 6:00 pm to 9:00 pm CDT

Linzy Hendrickson, PhD (OPDC) is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc.,… Read More

Clinical Perspectives on the Impact of Agitation in Alzheimer’s Dementia Among the Hispanic Community

Webinar September 18, 2024 12:00 pm to 1:00 pm EDT

Freddi Segal-Gidan, PA PhD is a volunteer and has declined payment for this activity. Daniel Jimenez, PhD is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. John Awad,… Read More

Virtual Event – Pathophysiology Of Agitation Associated With Alzheimer’s Dementia (AD) – The Potential Role Of The Norepinephrine, Serotonin & Dopamine (NSD) Neurotransmitter Systems

Regional/Local August 30, 2024 6:00 pm to 7:00 pm PDT

Speaker Lea Grinberg, MD, PhD is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)Speaker John Awad, MD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.… Read More

Now Leaving PsychU

This link will take you outside of the PsychU community website

PsychU

Sorry, this content is no longer available.

Stay Connected: